US Patent 7696163 Erythropoietin: remodeling and glycoconjugation of erythropoietin
Patent 7696163 was granted and assigned to Novo Nordisk on April, 2010 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
October 8, 2003
0
Date of Patent
April 13, 2010
0
Patent Application Number
10530972
0
Patent Citations Received
Patent Inventor Names
Robert J. Bayer
0
Xi Chen
0
Caryn Bowe
0
David A. Zopf
0
David James Hakes
0
Shawn DeFrees
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 7696163 Erythropoietin: remodeling and glycoconjugation of erythropoietin
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
